These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31299378)

  • 21. Advances in cobalt complexes as anticancer agents.
    Munteanu CR; Suntharalingam K
    Dalton Trans; 2015 Aug; 44(31):13796-808. PubMed ID: 26148776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cobalt(II) complexes with dipyridylamine and salicylaldehydes on cultured tumor and non-tumor cells: synthesis, crystal structure investigations and biological activity.
    Lalia-Kantouri M; Gdaniec M; Choli-Papadopoulou T; Badounas A; Papadopoulos CD; Czapik A; Geromichalos GD; Sahpazidou D; Tsitouroudi F
    J Inorg Biochem; 2012 Dec; 117():25-34. PubMed ID: 23078772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand.
    Abdel-Rahman LH; Abu-Dief AM; Aboelez MO; Hassan Abdel-Mawgoud AA
    J Photochem Photobiol B; 2017 May; 170():271-285. PubMed ID: 28456118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator.
    Ahn GO; Botting KJ; Patterson AV; Ware DC; Tercel M; Wilson WR
    Biochem Pharmacol; 2006 Jun; 71(12):1683-94. PubMed ID: 16620789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lawsone dimerization in cobalt(III) complexes toward the design of new prototypes of bioreductive prodrugs.
    Bustamante FL; Metello JM; de Castro FA; Pinheiro CB; Pereira MD; Lanznaster M
    Inorg Chem; 2013 Feb; 52(3):1167-9. PubMed ID: 23343393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural, electronic, and theoretical description of a series of cobalt clathrochelate complexes in the Co(III), Co(II) and Co(I) oxidation states.
    Nguyen MT; Charlot MF; Aukauloo A
    J Phys Chem A; 2011 Feb; 115(5):911-22. PubMed ID: 21226530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New mononuclear and binuclear oxomolybdenum(V) complexes containing NN chelator: Syntheses, DFT calculations, interaction with BSA protein and in vitro cytotoxic activity.
    Roy M; Biswal D; Sarkar O; Pramanik NR; Drew MGB; Sadhukhan P; Kundu M; Sil PC; Chakrabarti S
    J Inorg Biochem; 2019 Oct; 199():110755. PubMed ID: 31299376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and electronic structure of nonradical homoleptic pyridyl-azo-oxime complexes of cobalt(III) and the azo-oxime anion radical congener: an experimental and theoretical investigation.
    Pramanik S; Roy S; Ghorui T; Ganguly S; Pramanik K
    Dalton Trans; 2014 Apr; 43(14):5317-34. PubMed ID: 24513648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
    Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
    Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unprecedented structural variations in trinuclear mixed valence Co(II/III) complexes: theoretical studies, pnicogen bonding interactions and catecholase-like activities.
    Hazari A; Kanta Das L; Kadam RM; Bauzá A; Frontera A; Ghosh A
    Dalton Trans; 2015 Feb; 44(8):3862-76. PubMed ID: 25611163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copper(II), cobalt(II) and nickel(II) complexes of lapachol: synthesis, DNA interaction, and cytotoxicity.
    Tabrizi L; Talaie F; Chiniforoshan H
    J Biomol Struct Dyn; 2017 Nov; 35(15):3330-3341. PubMed ID: 27897079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
    Ware DC; Palmer BD; Wilson WR; Denny WA
    J Med Chem; 1993 Jun; 36(13):1839-46. PubMed ID: 8515422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azido- and chlorido-cobalt complex as carrier-prototypes for antitumoral prodrugs.
    Pires BM; Giacomin LC; Castro FA; Cavalcanti Ados S; Pereira MD; Bortoluzzi AJ; Faria RB; Scarpellini M
    J Inorg Biochem; 2016 Apr; 157():104-13. PubMed ID: 26881993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex.
    Yamamoto N; Renfrew AK; Kim BJ; Bryce NS; Hambley TW
    J Med Chem; 2012 Dec; 55(24):11013-21. PubMed ID: 23199008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, characterization and preliminary cytotoxicity evaluation of five lanthanide(III)-plumbagin complexes.
    Chen ZF; Tan MX; Liu YC; Peng Y; Wang HH; Liu HG; Liang H
    J Inorg Biochem; 2011 Mar; 105(3):426-34. PubMed ID: 21421129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, molecular structure, biological properties and molecular docking studies on Mn(II), Co(II) and Zn(II) complexes containing bipyridine-azide ligands.
    Thamilarasan V; Jayamani A; Sengottuvelan N
    Eur J Med Chem; 2015 Jan; 89():266-78. PubMed ID: 25462243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antitumor activity, metal uptake and reactivity with ascorbic acid and BSA of some gold(III) complexes with N,N'-ethylenediamine bidentate ester ligands.
    Pantelić N; Zmejkovski BB; Kolundžija B; Crnogorac MĐ; Vujić JM; Dojčinović B; Trifunović SR; Stanojković TP; Sabo TJ; Kaluđerović GN
    J Inorg Biochem; 2017 Jul; 172():55-66. PubMed ID: 28433833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.
    O'Neill ES; Kaur A; Bishop DP; Shishmarev D; Kuchel PW; Grieve SM; Figtree GA; Renfrew AK; Bonnitcha PD; New EJ
    Inorg Chem; 2017 Aug; 56(16):9860-9868. PubMed ID: 28766939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and antibacterial activity of FeIII, CoII, CuII and ZnII complexes probed by transmission electron microscopy.
    Fernandes C; Horn A; Vieira-da-Motta O; de Assis VM; Rocha MR; Mathias Lda S; Bull ES; Bortoluzzi AJ; Guimarães EV; Almeida JC; Russell DH
    J Inorg Biochem; 2010 Nov; 104(11):1214-23. PubMed ID: 20728942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.